Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients

British Journal of Cancer

Volumn 76, Issue 5, 1997, Pages 606-613

  Cariuk, P ^a   Lorite, M J ^a   Todorov, P T ^a   Field, W N ^a   Wigmore, S J ^b   Tisdale, M J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cachectic factor; Cancer patients; Glycoprotein; Protein degradation

Indexed keywords

ANTIGEN; MONOCLONAL ANTIBODY; PROSTAGLANDIN E2; PROTEOGLYCAN;

ADULT; AFFINITY CHROMATOGRAPHY; AGED; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BREAST CARCINOMA; CACHEXIA; CANCER; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CARCINOMA; MALE; MOUSE; MUSCLE ATROPHY; NONHUMAN; OVARY CARCINOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS INHIBITION; PROTEIN URINE LEVEL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEQUENCE HOMOLOGY; SILVER STAINING; SKELETAL MUSCLE; SPLEEN CELL; URINE; WEIGHT REDUCTION;

EID: 0030759546     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.433     Document Type: Article

References (37)

1. Balkwill F, Burke F, Talbot D, Tavernier J, Osborne R, Naylor S, Durhin H and Fiers W (1987) Evidence for tumour necrosis factor/cachectin production in cancer. Lancer ii:1229-1232
2. Beck SA and Tisdale MJ (1987) Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host. Cancer Res 47: 5919-5923
3. Belezario JE, Katz. M, Chenker E and Raw I (1991) Bioactivity of skeletal muscle proteolyis-inducing factors in the plasma proteins from cancer patients with weight loss. Br J Cancer 63: 705-710
4. Beutler B, Greenwald D, Hulmes. JD, Chang M, Pan, Y-CE, Mathison J, Ulevitch R and Cerami A (1985) Identity of tumour necrosis factor and the macrophage secreted factor cachectin. Nature 316: 552-554
5. Black K, Garrett TR and Mundy GR (1991) Chinese hamster ovary cells transfected with the murine IL-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor bearing nude mice. Enuocrintilogy 128: 2657-2659
6. Costa G (1977) Cachexia, the metabolic component of neoplastic disease. Cancer Res 37: 2327-2335
7. Costa G and Holland JF (1966) Effects of Krebs-2 carcinoma on the lipide mefdbolism of male Swiss mice. Cancer Rcs 22: 1081-1083
8. De Wys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HD, Engstrom PF, Ezdinlie Z, Horton J, Johnson GJ, Moertel CG, Oken MM, Perla C, Rosenbaum C, Sinerstein MN, Skeel RT, Sponzo RW and Tormey DC (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Meet 69: 491 -197
9. Emery PW, Edwards RHT, Rennie MJ, Souhami RI and Halliday D (1984) Protein synthesis in muscle measured in vivo in cachectic patients with cancer. Br Med J 289: 584-589
10. Gump FE and Kinney JM (1971) Energy balance and weight loss in burned patients. Arch Surf; 103: 442-448
11. Heber D, Byerley LO, Chi J, Grosvenor M, Bergman RN, Colemann M and Chlebowski RT (1986) Pathophysiology of malnutrition in the adult cancer patient. Cancer 58: 1867-1873
12. Hyltander A, Drott C, Korner U, Sandstrom R and Lundholm K (1991) Elevated energy expenditure in cancer patients with solid tumours. Eur J Cancer 27: 9-15
13. Ishibashi T, Shikama Y, Kimura H, Kawaguchi M, Uchida T, Yamamolo T, Okano A, Akiyama Y, Hirano T, Kishimoto T and Maruyama Y (1993) Thrombopoietic effects of interleukin-6 in long-term administration in mice. Exp Hematol 21: 640-646
14. Kien CL and Camitta BW (1983) Increased whole-body protein turnover in sick children with newly diagnosed leukemia or lymphoma. Cancer Res 43: 5586-5592
15. Kitada S, Hays EF and Mead JF (1980) A lipid mobilizing factor in serum of tumorbearing mice. Lipids 15: 168-174
16. Kitada S, Hays EF and Mead JF (1981) Characterization of a lipid mobilizing factor from tumors. Prog Lipid Res 20: 823-826
17. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277: 680-685
18. Levin L, Gevers W, Jardine L, De Guels FJM and Duncan EJ (1983) Serum amino acids in weight-losing patients with cancer and tuberculosis. Eur J Clin Oncol 19: 711-715
19. McDevitt TM and Tisdale MJ (1992) Tumour-associated hypoglycaemia in a murine cachexia model. Br J Cancer 66: 815-820
20. McDevitt TM, Todorov PT, Beck SA, Khan SH and Tisdale MJ (1995) Purification and characterization of a lipid-mobilizing factor associated with cachexia- inducing tumours in mice and humans. Cancer Res 55: 1458-1463
21. Mahony SM, Beck SA and Tisdale MJ (1988) Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia- inducing tumour. Br J Cancer 57: 385-389
22. Norton JA, Morley JF, Green MV, Carson ME and Morrison SD (1985) Parabiotic transfer of cancer anorexia/cachexia in male rats. Cancer Res 45: 5547-5552
23. O'Keefe SJD, Ogden J, Ramjee G and Rund J (1990) Contribution of elevated protein turnover and anorexia to cachexia in patients with hepatocellular carcinoma. Cancer Res 50: 1226-1231
24. Otiff A, Defo-Jones D, Boyer M, Martinez D, Kiefler D, Vuocolo G, Wolfe A and Socher SH (1987) Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 50: 555-563
25. Plumb JA, Fearon KCH, Carter KB and Preston T (1991) Energy expenditure and protein synthesis rates in an animal model of cancer cachexia. Clin Nutr 10: 23-29
26. Rennie MJ, Edwards RHT, Emery PW, Halliday D, Lundholm K and Millward DJ (1983) Depressed protein synthesis is the dominant characteristic of muscle wasting and cachexia. Clin Physiol 3: 387-398
27. 2α influence rates of protein turnover in skeletal and cardiac muscle. J Biol Chem 257: 1632-1638
28. Saarinen UM, Koskelo EK and Teppo AM (1990) TNF-cc in children with malignancies. Cancer Res 50: 592-595
29. Smith KL and Tisdale MJ (1993a) Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia. Br J Cancer 67: 680-685
30. Smith KL and Tisdale MJ (1993b) Mechanism of muscle protein degradation in cancer cachexia. Br J Cancer 68: 314-318
31. Socher SH, Martinez D, Craig JB. Kuhn G and Oliff A (1988) Tumor necrosis factor not detectable in patients with clinical cancer cachexia. J Natl Cancer 68: 595-598
32. Soda K, Kawakami M, Kashti A and Miyata M (1994) Characterization of mice bearing subclones of colon 26 adenocarcinoma disqualifies interleukin-6 as the sole inducer of cachexia. Jpn J Cancer Res 85: 1124-1130
33. Strelkov AB, Fields ALA and Baracos VE (1989) Effects of systemic inhibition of prostaglandin production on protein metabolism in tumor-bearing rats. Am J Physiol 257: C26l-C269
34. Todorov PT, Cariuk P, McDevitt T, Coles B, Fearon K and Tisdale M (1996a) Characterisation of a cancer cachectic factor. Nature 379: 739-742
35. Todorov PT, McDevitt TM, Cariuk P, Coles B, Deacon M and Tisdale MJ (1996b) Induction of muscle protein degradation and weight loss by a tumor product. Cancer Res 56: 1256-1261
36. WaalkesTP and Udenfriend SA (1957) A fluorimetric method for the estimation of tryrosine in plasma and tissues. J Lab Clin Med 50: 733-736
37. Warnold I, Lundholm K and Scherstein T (1978) Energy balance and body composition in cancer patients. Cancer Res 38: 1801-1807